Ji‐Hung Wang

1.0k total citations
67 papers, 709 citations indexed

About

Ji‐Hung Wang is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Ji‐Hung Wang has authored 67 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Cardiology and Cardiovascular Medicine, 14 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Surgery. Recurrent topics in Ji‐Hung Wang's work include Cardiovascular Health and Disease Prevention (18 papers), Cardiovascular Function and Risk Factors (12 papers) and Adipokines, Inflammation, and Metabolic Diseases (11 papers). Ji‐Hung Wang is often cited by papers focused on Cardiovascular Health and Disease Prevention (18 papers), Cardiovascular Function and Risk Factors (12 papers) and Adipokines, Inflammation, and Metabolic Diseases (11 papers). Ji‐Hung Wang collaborates with scholars based in Taiwan, United States and Gambia. Ji‐Hung Wang's co-authors include Bang‐Gee Hsu, Chung‐Jen Lee, Chiu-Fen Yang, Yu‐Chih Chen, Ming‐Chun Chen, Jen‐Pi Tsai, Chin‐Lon Lin, Yu‐Chih Chen, Yi-Hwei Li and Gen‐Min Lin and has published in prestigious journals such as PLoS ONE, Food Chemistry and International Journal of Environmental Research and Public Health.

In The Last Decade

Ji‐Hung Wang

66 papers receiving 683 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ji‐Hung Wang Taiwan	16	359	185	121	109	107	67	709
Niels C. F. Sandgaard Denmark	17	389 1.1×	95 0.5×	87 0.7×	77 0.7×	87 0.8×	31	675
Michael Resl Austria	15	462 1.3×	79 0.4×	103 0.9×	78 0.7×	219 2.0×	53	885
Atsushi Sakima Japan	16	350 1.0×	37 0.2×	143 1.2×	139 1.3×	110 1.0×	53	714
Andreas Christ Switzerland	13	401 1.1×	56 0.3×	105 0.9×	119 1.1×	86 0.8×	21	874
Yusuke Sata Australia	19	606 1.7×	74 0.4×	200 1.7×	179 1.6×	129 1.2×	52	1.0k
Yoram Shenker United States	17	653 1.8×	147 0.8×	127 1.0×	200 1.8×	339 3.2×	40	1.2k
Rodrigo O. Marañón United States	14	228 0.6×	53 0.3×	71 0.6×	50 0.5×	212 2.0×	32	646
Kazuya Setoh Japan	19	230 0.6×	95 0.5×	71 0.6×	99 0.9×	91 0.9×	61	860
Martin Bald Germany	16	192 0.5×	41 0.2×	231 1.9×	233 2.1×	222 2.1×	49	815
Bindu Chamarthi United States	16	213 0.6×	67 0.4×	179 1.5×	195 1.8×	311 2.9×	26	698

Countries citing papers authored by Ji‐Hung Wang

Since Specialization

Citations

This map shows the geographic impact of Ji‐Hung Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji‐Hung Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji‐Hung Wang more than expected).

Fields of papers citing papers by Ji‐Hung Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ji‐Hung Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji‐Hung Wang. The network helps show where Ji‐Hung Wang may publish in the future.

Co-authorship network of co-authors of Ji‐Hung Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Ji‐Hung Wang. A scholar is included among the top collaborators of Ji‐Hung Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ji‐Hung Wang. Ji‐Hung Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Ji‐Hung, et al.. (2025). Elevated Serum Trimethylamine N-Oxide Predicts Impaired Vascular Reactivity in Patients with Hypertension. Diagnostics. 15(18). 2400–2400. 1 indexed citations

Leu, Hsin‐Bang, Yen‐Wen Wu, Wei‐Kung Tseng, et al.. (2025). Prognostic utility of neutrophil gelatinase-associated lipocalin (NGAL) levels for cardiovascular events in patients with stable coronary artery disease treated with percutaneous coronary intervention: a prospective longitudinal cohort study. Biomarker Research. 13(1). 24–24. 1 indexed citations

Wang, Ji‐Hung, et al.. (2025). Endothelial dysfunction in chronic kidney disease: Mechanisms, biomarkers, diagnostics, and therapeutic strategies. Tzu Chi Medical Journal. 37(2). 125–134. 5 indexed citations

Lin, Liang‐Yu, Ting‐Ting Chang, Chin‐Chou Huang, et al.. (2024). Novel prognostic impact and cell specific role of endocan in patients with coronary artery disease. Clinical Research in Cardiology. 114(8). 952–968. 4 indexed citations

Huang, Chin‐Chou, Hsin‐Bang Leu, Wei-Hsian Yin, et al.. (2023). Inflammation and renal function decline in chronic coronary syndrome: a prospective multicenter cohort study. BMC Cardiovascular Disorders. 23(1). 564–564. 4 indexed citations

Wang, Huisheng, Marthandam Asokan Shibu, Ji‐Hung Wang, et al.. (2022). Clinical course of patients with severe SARS-CoV-2 infection co-treatment with Jin Si Herbal Tea in Eastern Taiwan: A retrospective cohort study. Journal of Herbal Medicine. 36. 100610–100610. 5 indexed citations

Chen, Ming‐Chun, Bang‐Gee Hsu, Chung‐Jen Lee, & Ji‐Hung Wang. (2020). High-Serum Angiopoietin-Like Protein 3 Levels Associated with Cardiovascular Outcome in Patients with Coronary Artery Disease. International Journal of Hypertension. 2020. 1–7. 10 indexed citations

Hsu, Bang‐Gee, et al.. (2020). Serum indoxyl sulfate as a potential biomarker of aortic arterial stiffness in coronary artery disease. Nutrition Metabolism and Cardiovascular Diseases. 30(12). 2320–2327. 12 indexed citations

Hsu, Bang‐Gee, et al.. (2019). <p>Metabolic Syndrome With Aortic Arterial Stiffness And First Hospitalization Or Mortality In Coronary Artery Disease Patients</p>. Diabetes Metabolic Syndrome and Obesity. Volume 12. 2065–2073. 7 indexed citations

10.

Chen, Ming‐Chun, Ji‐Hung Wang, Chung‐Jen Lee, & Bang‐Gee Hsu. (2018). Association between hyperleptinemia and cardiovascular outcomes in patients with coronary artery disease. Therapeutics and Clinical Risk Management. Volume 14. 1855–1862. 19 indexed citations

11.

Wang, Ji‐Hung, et al.. (2018). Positive correlation of the serum angiopoietin-like protein 3 levels with the aortic augmentation index in patients with coronary artery disease. Therapeutics and Clinical Risk Management. Volume 14. 231–236. 8 indexed citations

12.

Chen, Ming‐Chun, Chung‐Jen Lee, Chiu-Fen Yang, et al.. (2017). Low serum adiponectin level is associated with metabolic syndrome and is an independent marker of peripheral arterial stiffness in hypertensive patients. Diabetology & Metabolic Syndrome. 9(1). 49–49. 27 indexed citations

13.

Wang, Ji‐Hung, Chung‐Jen Lee, Chiu-Fen Yang, Yu‐Chih Chen, & Bang‐Gee Hsu. (2017). Serum resistin as an independent marker of aortic stiffness in patients with coronary artery disease. PLoS ONE. 12(8). e0183123–e0183123. 17 indexed citations

14.

Tsai, Jen‐Pi, Ji‐Hung Wang, Mei‐Ling Chen, et al.. (2016). Association of serum leptin levels with central arterial stiffness in coronary artery disease patients. BMC Cardiovascular Disorders. 16(1). 80–80. 44 indexed citations

15.

Chang, Huai-Ren, et al.. (2014). N-Terminal Pro-B-Type Natriuretic Peptide Is Inversely Associated With Metabolic Syndrome in Hypertensive Patients. The American Journal of the Medical Sciences. 348(3). 210–214. 6 indexed citations

16.

Wang, Ji‐Hung, et al.. (2014). N-terminal pro-B-type natriuretic peptide level inversely associates with metabolic syndrome in elderly persons. Diabetology & Metabolic Syndrome. 6(1). 15–15. 7 indexed citations

17.

Li, Yi-Hwei, Gen‐Min Lin, Chin‐Lon Lin, Ji‐Hung Wang, & Chih‐Lu Han. (2013). Relation of estimated glomerular filtration rate and body mass index to mortality in non-dialysis patients with coronary artery disease: A report from the ET-CHD registry, 1997–2003. Journal of Cardiology. 62(3). 144–150. 3 indexed citations

18.

Lin, Gen‐Min, Yi-Hwei Li, Chin‐Lon Lin, Ji‐Hung Wang, & Chih‐Lu Han. (2013). Gender differences in the impact of diabetes on mortality in patients with established coronary artery disease: A report from the Eastern Taiwan integrated health care delivery system of Coronary Heart Disease (ET-CHD) registry, 1997–2006. Journal of Cardiology. 61(6). 393–398. 15 indexed citations

19.

Lin, Gen‐Min, Yi-Hwei Li, Chin‐Lon Lin, Ji‐Hung Wang, & Chih‐Lu Han. (2013). Relation of body mass index to bleeding events among patients with percutaneous coronary intervention: A meta-analysis. International Journal of Cardiology. 168(5). 4831–4835. 3 indexed citations

20.

Wang, Ji‐Hung, Yi‐Maun Subeq, Wen‐Chin Tsai, Ru‐Ping Lee, & Bang‐Gee Hsu. (2008). IntravenousN-acetylcysteine with Saline Hydration Improves Renal Function and Ameliorates Plasma Total Homocysteine in Patients Undergoing Cardiac Angiography. Renal Failure. 30(5). 527–533. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact